(b) The factors and methodology for
determining the public need for allogeneic BMT services shall include, but not
be limited to, the following:
(1) The need
for BMT services shall be planned on a statewide basis.
(2) Based on the current status of BMT
technology, the number of people expected to be candidates for BMT therapy is
13.2 per million population per year. This will be reviewed on an annual basis
to determine if any adjustment is indicated.
(3) The capacity of each BMT bed is six
patients/year.
(4) A BMT service
shall have a minimum of four beds.
(5) Priority consideration will be given to
applicants that propose to provide this service within the facility's current
capacity.
(6) Where public need is
established herein, priority consideration will be given to applicants that
agree to serve the medically indigent and patients regardless of the source of
payment.
(7) In addition, each
applicant applying to initiate a BMT service must meet the following standards:
(i) Each applicant must demonstrate the
availability of a bone marrow transplant team under the direction of a
full-time medical director with training in immunology or hematology who had
advanced training and experience in bone marrow transplantation.
(ii) The bone marrow transplant team shall
include specialists in the following areas: chemotherapy, radiation therapy,
social work, nursing, infectious disease control, immunology, oncology,
hematology, and expertise in intensive cardiopulmonary medicine.
(iii) The transplant program shall be
supported by a blood bank with a capacity to support four to six patients/day.
This requires the availability of a blood separator, a central blood
repository, and an irradiator for blood products.
(iv) The bone marrow transplantation program
shall provide or make arrangements for the harvesting of bone marrow.
(v) The services of an immunogeneticist and a
cytogeneticist shall be available to the transplant program.
(vi) The transplant program shall have
available clinical laboratories possessing permits issued under article 5,
title 5 of the Public Health Law, in the categories of: virology, diagnostic
immunology, bacteriology, mycology, mycobacteriology, parasitology,
cytogenetics, cellular immunology and histocompatibility.
(vii) There shall be an organized follow-up
program for transplant patients following discharge, including data management
resources to maintain records on the long-term survival of transplant
patients.
(viii) Each facility
providing BMT services shall agree to provide annual reports to the Department
of Health on utilization levels and patient origin data.
